Portfolio company
Iambic Therapeutics
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
5 investors
Sectors
About
This company develops artificial intelligence platforms for drug discovery and clinical-stage therapeutics for biopharmaceutical partners and healthcare sectors.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Iambic
This company develops small molecule medicines for patients with cancer using an artificial intelligence drug discovery platform.
Generate Biomedicine
This company develops protein-based therapeutics using a generative artificial intelligence platform for pharmaceutical partners and biotechnology firms.
Valohealth
This company develops an artificial intelligence platform for drug discovery and development to assist pharmaceutical partners in creating new medical treatments.
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
Cardiatec
This company develops an artificial intelligence platform to identify novel drug targets and therapeutics for cardiovascular diseases for the pharmaceutical and healthcare industries.
Inceptive Nucleics
This company develops artificial intelligence models to design novel RNA-based medicines and biotechnologies for pharmaceutical and biotechnology partners.
Nabla Bio
This company develops generative artificial intelligence and high-throughput screening platforms to design therapeutic antibodies for pharmaceutical and biotechnology partners.
Computational drug discovery platform
This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.
